Alnylam Pharmaceuticals
ALNY
ALNY
518 hedge funds and large institutions have $29.1B invested in Alnylam Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 87 funds opening new positions, 194 increasing their positions, 164 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
5% more funds holding
Funds holding: 495 → 518 (+23)
3.65% more ownership
Funds ownership: 91.08% → 94.73% (+3.6%)
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
Holders
518
Holding in Top 10
6
Calls
$703M
Puts
$600M
Top Buyers
| 1 | +$534M | |
| 2 | +$530M | |
| 3 | +$175M | |
| 4 |
BlackRock
New York
|
+$127M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$125M |
Top Sellers
| 1 | -$243M | |
| 2 | -$144M | |
| 3 | -$117M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$80.8M |
| 5 |
VPC
Vestal Point Capital
New York
|
-$52.3M |